Regulatory Watch: FDA denied Lantheus’ application for a new PET imaging agent (LNTH-2501), pointing to manufacturing issues at a third-party site, delaying access for neuroendocrine tumor patients. Clinical Pipeline: Zambon and Amneal won a positive CHMP opinion for Hopledo® (modified-release levodopa/carbidopa) for Parkinson’s with moderate-to-severe motor fluctuations, with potential EU availability starting October 2026. Health Tech & Supply Chain: Nano-X Imaging warned about “going concern” risk as losses deepen and cash burn continues, while Xerafy’s smart RFID labels for pharma and healthcare packaging are set for AIPIA’s Innovation Stage at CPHI South East Asia. Public Health & Prevention: North Dakota’s Minot State University received a CDC grant to improve early hearing detection tracking, and the UK’s Obesity Pathway Innovation Program is set to receive major funding for digital weight-management tools and support. Workforce & Care Delivery: Fort Stewart’s Medical Simulation Training Center earned top Army ranking, highlighting ongoing investment in medical readiness. Business of Health: Futura Medical is switching US distribution for Eroxon from Haleon to Market Performance Group after a slower-than-expected run. Fraud & Compliance: An Ohio pharmacist pleaded guilty to helping defraud the IRS, tied to alleged diversion of pharmacy proceeds.